|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 901 NEW YORK AVENUE, NW, #510 |
Address2 | |
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Irving |
State | TX |
Zip Code | 75039 |
Country | USA |
|
5. Senate ID# 40021-00012
|
||||||||
|
6. House ID# 313240000
|
||||||||
| TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Michael J. Regier, Senior Vice President Legal and Corporate Affairs and General Counsel |
Date | 01/14/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Health Care Reform (H.R. 3962, H.R. 3590) - monitored negotiations and legislative action on the major health reform bills. Advocated for limiting reductions in Medicare reimbursement to hospitals to the level agreed to by key hospital organizations and White House and Congress. Tracked the inclusion of several payment reform initiatives included in both bills, specifically provisions on Medicare Value Based Purchasing, denying Medicare payments for hospital readmissions, proposals to bundle hospital
and post acute payments.
Gainsharing - tracked legislative and regulatory efforts to implement gainsharing arrangements that align financial incentives for hospitals and physicians. Tracked and engaged on the implementation of the Centers for Medicare & Medicaid Services (CMS) Acute Care Episode (ACE) demonstration project.
Expansion of Medicaid - monitored proposals in the House and Senate to expand Medicaid to 150% and 133% of Federal Poverty Level respectively.
Monitored proposals in the Senate Health Reform bill (H.R. 3590) to create an independent Medicare Advisory Body, which would have great authority to make changes to Medicare payment policy.
Medicare buy-in - (H.R. 3590) - expressed opposition to proposals that would have allowed individuals aged 55-64 to buy in to the Medicare program.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Goodman |
|
|
|
Cidette |
Perrin |
|
|
|
Steven |
Rixen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Care Reform Legislation (H.R. 3590, H.R. 3962 ) - monitored the development and negotiations over the health care reform bills considered in the House and Senate. Supported proposals that would have reduced the number of uninsured Americans. Expressed opposition to the creation of a public insurance option that was based on Medicare rates.
Group Purchasing Organizations - monitored the negotiations of the health care reform bills being considered in Congress for proposals that would negatively impact hospital group purchasing organizations. General outreach to illustrate the value that group purchasing organizations deliver to hospitals.
Health Care Information Technology - monitored the health care reform legislation for proposals that would expand privacy requirements beyond those established in the American Recovery and Reinvestment Act (ARRA) passed in early 2009. Supported proposals to expand funding opportunities for health care information technology for hospitals. Monitored the development of "meaningful use" regulations, and supported efforts that would provide hospitals greater opportunities to invest in health IT and receive reimbursement under ARRA.
Unique Device Identification - Supported legislative language in the House health reform bill (H.R. 3962) that would require the Food and Drug Administration to issue regulations requiring Unique Device Identification for medical devices. Supported the utilization of a single supply chain standard for UDI and endorsed GS1 standards.
340B (of the Public Health Services Act) Drug Pricing - monitored proposal in H.R. 3590 that would expand the 340B drug discount program to inpatient drugs for eligible hospitals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Goodman |
|
|
|
Cidette |
Perrin |
|
|
|
Steven |
Rixen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Not-for-profit hospital tax exemption issues - monitored proposals in the House and Senate health care reform legislation to expand requirements for not-for-profit hospitals to obtain and maintain tax exempt status. Advocated for reasonable requirements that would be managable for tax-exempt hospitals to implement.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Goodman |
|
|
|
Cidette |
Perrin |
|
|
|
Steven |
Rixen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |